Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Just For You 3 Cash-Flow Machines Investors May Want Heading Into 2026Authored by Nathan Reiff. Posted: 1/2/2026. 
Key Takeaways - Strong cash flow is a crucial indicator of a company's healthy operations, enabling it to pay down debt, enhance shareholder value, and sustain long-term growth.
- Semiconductor firm Qualcomm stands out for its 15% year-over-year cash flow growth in the last quarter.
- Gilead Sciences and Exxon Mobil both have healthy cash flows, allowing for attractive dividend distributions.
Of the host of financial metrics investors might consider when deciding whether to buy shares of a target company, cash flow is among the most important. Operating cash flow reflects how a firm functions day to day and demonstrates the company's ability to generate money from sales or other sources and to pay salaries, taxes, and other expenses. Free cash flow shows what remains after accounting for operating expenses and capital expenditures (CapEx)—the discretionary cash available for expansion, shareholder returns, mergers and acquisitions, and more. A company's cash flow keeps it operating, supports growth and expansion, and reduces the risk of bankruptcy. Many investors also view it as harder to manipulate than net income, which can be affected by accounting methods. Heading into the new year, investors seeking strong cash flow may want to consider the firms below. Record Free Cash Flow for a Growing Semiconductor Firm A tiny government task force just wrapped up 20 years of work.
And buried in their federal filings, I found something remarkable:
American citizens now have a legal birthright claim to something previously inaccessible.
Under U.S. law, you can stake your claim right now. The name and ticker are available here now >>> Qualcomm Inc. (NASDAQ: QCOM) is a major provider of semiconductors for phones, vehicles, and a variety of smart devices. Shares showed steady momentum through much of 2025, trending upward from April through year-end, but Qualcomm's rally has still brought it short of the astronomical valuations some of its semiconductor rivals enjoy. For investors focused on cash generation, Qualcomm stands out: it reported $12.8 billion in free cash flow in the most recently reported quarter, up 15% year over year and a quarterly record for the company. Operating cash flow rose significantly as well, driven by strong sales in both the handset and automotive divisions. Despite sizable capital spending, Qualcomm finished the quarter with about $7.8 billion in cash reserves—roughly flat year over year—indicating a solid financial position heading into the next quarter. Qualcomm's healthy cash flow should allow continued expansion into high-demand data-center markets in 2026 while maintaining its commitment to shareholder returns—the company's dividend yield is an attractive 2.08%. High Margins and Growing Sales Drive Continued Cash Flow Success Biopharma giant Gilead Sciences Inc. (NASDAQ: GILD), known for antiviral therapies for HIV, hepatitis, and other conditions, benefits from rising sales and strong margins. In the latest quarter, its HIV medication Descovy saw sales surge 20% year over year. Gilead's portfolio spans liver disease, oncology, and other areas, so it does not rely on a single product or therapeutic focus. Free cash flow in the quarter was nearly $4 billion, with operating cash flow of $4.1 billion. Cash flow is especially important for biopharma companies because the industry requires substantial, ongoing R&D investment. Gilead is in a healthy position to continue developing its pipeline thanks to its cash reserves and robust cash generation. Having cash on hand also enables Gilead to pay a compelling dividend relative to many of its healthcare peers, with a dividend yield of 2.57% and a payout ratio just under 49%. Shares of GILD climbed more than a third in 2025, and analysts still see room for further growth in the new year. Huge Oil and Gas Operation Still Maintains Strong Cash Flow Exxon Mobil Corp. (NYSE: XOM), the second-largest oil and gas company by market capitalization, is valued at more than $500 billion. Its cash flow mirrors the scale of its extensive upstream and refining operations. Operating cash flow was $14.8 billion in the latest quarter, and free cash flow came in at $6.3 billion despite relatively high CapEx—typical for a capital-intensive industry like oil and gas. Exxon maintains healthy liquidity and cash flow, which supports ongoing operations and potential expansion. That strong cash generation has also allowed Exxon to be a significant dividend payer, with a yield of 3.42% and more than four decades of consistent dividend increases.
| 
Post a Comment
Post a Comment